EVOTEC SE - SPON ADR (EVO:NASDAQ)
$2.99 0.12 (4.1812%)
Analysed EVOTEC SE - SPON ADR (EVO:NASDAQ) News Sources
Evotec Receives Grants to Advance Tuberculosis Treatment
30-04-2026
yahoo.com
Evotec Announces Nomination of First Preclinical Development Candidate in Dermatology Collaboration with Almirall
04-05-2026
yahoo.com
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday as US-Iran Tensions Escalate Near Strait of Hormuz
04-05-2026
yahoo.com
Evotec (XTRA:EVT) Valuation Check As CFO Transition Draws Fresh Attention To The Stock
05-05-2026
yahoo.com
Evotec Q1 Earnings Call Highlights
06-05-2026
marketbeat.com
European Stocks Estimated To Be Up To 30.8% Below Their Intrinsic Value
11-05-2026
yahoo.com
European Market: Nokian Renkaat Oyj And Two Other Stocks That May Be Priced Below Estimated Value
11-05-2026
yahoo.com
Evotec SE Successfully Placed €116.1 Million Convertible Bonds
12-05-2026
yahoo.com
Evotec (EVO) Nominates First Preclinical Development Candidate from Almirall Alliance
13-05-2026
yahoo.com
QuickLogic Posts Downbeat Q1 Results, Joins Resideo Technologies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
13-05-2026
yahoo.com
What is the current price of EVOTEC SE - SPON ADR (EVO:NASDAQ)?
The current price of EVOTEC SE - SPON ADR (EVO:NASDAQ) is $2.99.
EVOTEC SE - SPON ADR (EVO:NASDAQ) absolute price change since previous trading day?
The absolute price change of EVOTEC SE - SPON ADR (EVO:NASDAQ) since the previous trading day is $0.12.
EVOTEC SE - SPON ADR (EVO:NASDAQ) percentage price change since previous trading day?
The percentage price change of EVOTEC SE - SPON ADR (EVO:NASDAQ) since the previous trading day is 4.1812%.
What is the most recent average sentiment score for EVOTEC SE - SPON ADR (EVO:NASDAQ)?
The most recent average sentiment score for EVOTEC SE - SPON ADR (EVO:NASDAQ) is 51 out of 100.
What is the most recent average sentiment for EVOTEC SE - SPON ADR (EVO:NASDAQ)?
The most recent sentiment for EVOTEC SE - SPON ADR (EVO:NASDAQ) is .
SEC-8K** Filing Available For EVOTEC SE - SPON ADR (EVO:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.